A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
March 6, 2026
2-(2-Aminothiazol-4-yl) acetic acid hydrochloride
2-(2-AMINOTHIAZOL-4-YL)ACETICACIDHCL，2-(2-aminothiazol-4-yl)aceticacid, hydrochloide; ATA HYDROCHLORIDE
CAS:66659-20-9
Chemical Formula:C5H7ClN2O2S
MW:194.64
Availability: R&D; Commercialization
2-(2-Aminothiazol-4-yl) acetic acid hydrochloride
⬤ CAS No.66659-20-9
⬤ Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| English name | 2-(2-Aminothiazol-4-yl) acetic acid hydrochloride |
| CAS No. | 66659-20-9 |
| Chemical formula | C5H7ClN2O2S |
| Molecular weight | 194.64 |
| Related categories | Pharmaceutical intermediates; Chemical raw materials;Intermediates; Raw materials; Chemical raw materials; Impurity reference substances; Organic acids; (intermediate of cefotiam); Pharmaceutical raw materials; Pharmaceutical raw material intermediates |
| Mol | 66659-20-9.mol |
| EINECS | 1308068-626-2 |
| Melting point | 152°C |
| Storage conditions | under inert gas (nitrogen or Argon) at 2-8°C |
| Solubility | Slightly soluble in methanol |
| form | solid |
| color | White to off-white |
| CAS | 66659-20-9 |
| Customs Tariff Code | 2934100090 |
| RTECS Number | YQ1509000 |
| GHS Hazard Pictograms | GHS07 |
| Signal Word | Warning |
| Hazard Statements | H315 (Causes skin irritation), H319 (Causes serious eye irritation), H335 (May cause respiratory irritation) |
| Physical State | White to off-white crystalline powder |
| Storage Conditions | Inert atmosphere, 2-8°C (In an inert gas environment, at 2-8°C) |
| Solubility | Slightly soluble in methanol |
| Precautionary Statements | It is recommended to avoid inhaling dust, wear protective respirators, and take appropriate first aid measures immediately if accidentally inhaled or contact with eyes. |
| Storage conditions | Should be stored in a dry, well-ventilated place, away from direct sunlight and high temperatures. |
| Use |
1. Mainly used as organic raw materials and pharmaceutical intermediates. 2. Used in the synthesis of antibiotics such as cefotiam. 3. Plays an important role in chemical synthesis and drug development. |
Customer Reviews
Real customer feedback
Alexandra Thompson
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Ethan Lee
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Sophia Chen
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Lucas Rodriguez
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
What's News
Latest news at Tianming
CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?
Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.
March 3, 2026
Case Study: Improving Yield & Purity Through Route Optimization
This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity of Active Pharmaceutical Ingredients (APIs).
February 27, 2026
Still Have Questions？
If you still have questions or need more information, our team is here to help. Please don’t hesitate to contact us for personalized assistance.